🔗 Visit the ClinicalTrials.gov page for NCT01281475
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Angelman syndrome: review of clinical and molecular aspects. | Appl Clin Genet | 2014 | 1.14 |
| 2 | Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome. | J Clin Invest | 2012 | 0.97 |
| 3 | Angelman Syndrome. | Neurotherapeutics | 2015 | 0.90 |
| 4 | Potential therapeutic approaches for Angelman syndrome. | Expert Opin Ther Targets | 2015 | 0.77 |